Interleukin-8 in chronic renal failure and dialysis patients
- PMID: 7816257
Interleukin-8 in chronic renal failure and dialysis patients
Abstract
A total of 105 patients participated in this study, including 10 with chronic glomerulonephritis with normal renal function (CGN patients), 36 uraemic patients (CRF patients), 19 continuous ambulatory peritoneal dialysis patients (CAPD) without peritonitis, three CAPD patients with peritonitis, 37 patients undergoing chronic haemodialysis (HD) divided into short-term HD, 15 patients; medium-term HD, 12 patients; and long-term HD, 10 patients. IL-8 and two other proinflammatory cytokines, IL-6 and TNF alpha were tested using a specific immunoassay. IL-8, IL-6, and TNF alpha serum levels were significantly increased in patients with chronic renal failure compared to their levels in normal individuals (P < 0.0001, P < 0.05 and P < 0.0001 respectively). The most pronounced increment in IL-8, IL-6 and TNF alpha serum levels was observed in CAPD patients (P < 0.0001). CAPD patients without peritonitis showed relatively low levels of IL-8 or IL-6 in peritoneal dialysate effluents (PDE), whereas PDE-TNF alpha were not detectable in almost all patients tested. Patients with peritonitis showed very high serum and PDE levels of IL-8, IL-6 and TNF alpha. The clinical recovery from peritonitis was characterized by a rapid fall in IL-8, IL-6 and TNF alpha in serum and dialysate. HD patients showed a significant increase in serum levels of IL-8 and also IL-6 and TNF alpha compared to normal individuals (P < 0.05, P < 0.05 and P < 0.01 respectively).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.Mediators Inflamm. 2004 Jun;13(3):201-4. doi: 10.1080/09511920410001713493. Mediators Inflamm. 2004. PMID: 15223612 Free PMC article.
-
Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.Med Pregl. 2007;60 Suppl 2:53-7. Med Pregl. 2007. PMID: 18928158
-
Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients.Clin Nephrol. 1995 Apr;43(4):243-8. Clin Nephrol. 1995. PMID: 7606878
-
Is CAPD competitive with haemodialysis for long-term treatment of uraemic patients?Nephrol Dial Transplant. 1989;4(4):244-53. doi: 10.1093/oxfordjournals.ndt.a091867. Nephrol Dial Transplant. 1989. PMID: 2502731 Review.
-
Forces determining selection of uremia therapy.Adv Nephrol Necker Hosp. 1984;13:151-62. Adv Nephrol Necker Hosp. 1984. PMID: 6433665 Review. No abstract available.
Cited by
-
A Critical Role of Neutrophil-Driven Amplification of Chronic Microinflammation in the Biocompatibility of Hemodialysis.Int J Mol Sci. 2025 Jul 4;26(13):6472. doi: 10.3390/ijms26136472. Int J Mol Sci. 2025. PMID: 40650247 Free PMC article. Review.
-
Role of Uremic Toxins in Vascular Inflammation Associated with Chronic Kidney Disease.J Clin Med. 2024 Nov 26;13(23):7149. doi: 10.3390/jcm13237149. J Clin Med. 2024. PMID: 39685608 Free PMC article.
-
Uremic Toxins Induce ET-1 Release by Human Proximal Tubule Cells, which Regulates Organic Cation Uptake Time-Dependently.Cells. 2015 Jun 26;4(3):234-52. doi: 10.3390/cells4030234. Cells. 2015. PMID: 26132391 Free PMC article.
-
Mechanisms of haemolysis-induced kidney injury.Nat Rev Nephrol. 2019 Nov;15(11):671-692. doi: 10.1038/s41581-019-0181-0. Epub 2019 Aug 27. Nat Rev Nephrol. 2019. PMID: 31455889 Review.
-
Associations of interleukin-6, C-reactive protein and serum amyloid A with mortality in haemodialysis patients.Nephrology (Carlton). 2008 Oct;13(7):593-600. doi: 10.1111/j.1440-1797.2008.01021.x. Epub 2008 Sep 25. Nephrology (Carlton). 2008. PMID: 18826487 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical